1 Study Coverage 1.1 Anti-Infective Medications Product Introduction 1.2 Market by Type 1.2.1 Global Anti-Infective Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Antivirals 1.2.3 Antibacterials 1.2.4 Antifungals 1.3 Market by Application 1.3.1 Global Anti-Infective Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Retail Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anti-Infective Medications Sales Estimates and Forecasts 2017-2028 2.2 Global Anti-Infective Medications Revenue Estimates and Forecasts 2017-2028 2.3 Global Anti-Infective Medications Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Anti-Infective Medications Sales by Region 2.4.1 Global Anti-Infective Medications Sales by Region (2017-2022) 2.4.2 Global Sales Anti-Infective Medications by Region (2023-2028) 2.5 Global Anti-Infective Medications Revenue by Region 2.5.1 Global Anti-Infective Medications Revenue by Region (2017-2022) 2.5.2 Global Anti-Infective Medications Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Anti-Infective Medications Sales by Manufacturers 3.1.1 Global Top Anti-Infective Medications Manufacturers by Sales (2017-2022) 3.1.2 Global Anti-Infective Medications Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Infective Medications in 2021 3.2 Global Anti-Infective Medications Revenue by Manufacturers 3.2.1 Global Anti-Infective Medications Revenue by Manufacturers (2017-2022) 3.2.2 Global Anti-Infective Medications Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Anti-Infective Medications Revenue in 2021 3.3 Global Anti-Infective Medications Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Anti-Infective Medications Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Anti-Infective Medications Sales by Type 4.1.1 Global Anti-Infective Medications Historical Sales by Type (2017-2022) 4.1.2 Global Anti-Infective Medications Forecasted Sales by Type (2023-2028) 4.1.3 Global Anti-Infective Medications Sales Market Share by Type (2017-2028) 4.2 Global Anti-Infective Medications Revenue by Type 4.2.1 Global Anti-Infective Medications Historical Revenue by Type (2017-2022) 4.2.2 Global Anti-Infective Medications Forecasted Revenue by Type (2023-2028) 4.2.3 Global Anti-Infective Medications Revenue Market Share by Type (2017-2028) 4.3 Global Anti-Infective Medications Price by Type 4.3.1 Global Anti-Infective Medications Price by Type (2017-2022) 4.3.2 Global Anti-Infective Medications Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Anti-Infective Medications Sales by Application 5.1.1 Global Anti-Infective Medications Historical Sales by Application (2017-2022) 5.1.2 Global Anti-Infective Medications Forecasted Sales by Application (2023-2028) 5.1.3 Global Anti-Infective Medications Sales Market Share by Application (2017-2028) 5.2 Global Anti-Infective Medications Revenue by Application 5.2.1 Global Anti-Infective Medications Historical Revenue by Application (2017-2022) 5.2.2 Global Anti-Infective Medications Forecasted Revenue by Application (2023-2028) 5.2.3 Global Anti-Infective Medications Revenue Market Share by Application (2017-2028) 5.3 Global Anti-Infective Medications Price by Application 5.3.1 Global Anti-Infective Medications Price by Application (2017-2022) 5.3.2 Global Anti-Infective Medications Price Forecast by Application (2023-2028) 6 North America 6.1 North America Anti-Infective Medications Market Size by Type 6.1.1 North America Anti-Infective Medications Sales by Type (2017-2028) 6.1.2 North America Anti-Infective Medications Revenue by Type (2017-2028) 6.2 North America Anti-Infective Medications Market Size by Application 6.2.1 North America Anti-Infective Medications Sales by Application (2017-2028) 6.2.2 North America Anti-Infective Medications Revenue by Application (2017-2028) 6.3 North America Anti-Infective Medications Market Size by Country 6.3.1 North America Anti-Infective Medications Sales by Country (2017-2028) 6.3.2 North America Anti-Infective Medications Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Anti-Infective Medications Market Size by Type 7.1.1 Europe Anti-Infective Medications Sales by Type (2017-2028) 7.1.2 Europe Anti-Infective Medications Revenue by Type (2017-2028) 7.2 Europe Anti-Infective Medications Market Size by Application 7.2.1 Europe Anti-Infective Medications Sales by Application (2017-2028) 7.2.2 Europe Anti-Infective Medications Revenue by Application (2017-2028) 7.3 Europe Anti-Infective Medications Market Size by Country 7.3.1 Europe Anti-Infective Medications Sales by Country (2017-2028) 7.3.2 Europe Anti-Infective Medications Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Anti-Infective Medications Market Size by Type 8.1.1 Asia Pacific Anti-Infective Medications Sales by Type (2017-2028) 8.1.2 Asia Pacific Anti-Infective Medications Revenue by Type (2017-2028) 8.2 Asia Pacific Anti-Infective Medications Market Size by Application 8.2.1 Asia Pacific Anti-Infective Medications Sales by Application (2017-2028) 8.2.2 Asia Pacific Anti-Infective Medications Revenue by Application (2017-2028) 8.3 Asia Pacific Anti-Infective Medications Market Size by Region 8.3.1 Asia Pacific Anti-Infective Medications Sales by Region (2017-2028) 8.3.2 Asia Pacific Anti-Infective Medications Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Anti-Infective Medications Market Size by Type 9.1.1 Latin America Anti-Infective Medications Sales by Type (2017-2028) 9.1.2 Latin America Anti-Infective Medications Revenue by Type (2017-2028) 9.2 Latin America Anti-Infective Medications Market Size by Application 9.2.1 Latin America Anti-Infective Medications Sales by Application (2017-2028) 9.2.2 Latin America Anti-Infective Medications Revenue by Application (2017-2028) 9.3 Latin America Anti-Infective Medications Market Size by Country 9.3.1 Latin America Anti-Infective Medications Sales by Country (2017-2028) 9.3.2 Latin America Anti-Infective Medications Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Anti-Infective Medications Market Size by Type 10.1.1 Middle East and Africa Anti-Infective Medications Sales by Type (2017-2028) 10.1.2 Middle East and Africa Anti-Infective Medications Revenue by Type (2017-2028) 10.2 Middle East and Africa Anti-Infective Medications Market Size by Application 10.2.1 Middle East and Africa Anti-Infective Medications Sales by Application (2017-2028) 10.2.2 Middle East and Africa Anti-Infective Medications Revenue by Application (2017-2028) 10.3 Middle East and Africa Anti-Infective Medications Market Size by Country 10.3.1 Middle East and Africa Anti-Infective Medications Sales by Country (2017-2028) 10.3.2 Middle East and Africa Anti-Infective Medications Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Abbott 11.1.1 Abbott Corporation Information 11.1.2 Abbott Overview 11.1.3 Abbott Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Abbott Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Abbott Recent Developments 11.2 Astellas Pharma 11.2.1 Astellas Pharma Corporation Information 11.2.2 Astellas Pharma Overview 11.2.3 Astellas Pharma Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Astellas Pharma Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Astellas Pharma Recent Developments 11.3 Bayer 11.3.1 Bayer Corporation Information 11.3.2 Bayer Overview 11.3.3 Bayer Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Bayer Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Bayer Recent Developments 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Corporation Information 11.4.2 Bristol-Myers Squibb Overview 11.4.3 Bristol-Myers Squibb Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Bristol-Myers Squibb Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Bristol-Myers Squibb Recent Developments 11.5 Daiichi Sankyo 11.5.1 Daiichi Sankyo Corporation Information 11.5.2 Daiichi Sankyo Overview 11.5.3 Daiichi Sankyo Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Daiichi Sankyo Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Daiichi Sankyo Recent Developments 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Corporation Information 11.6.2 GlaxoSmithKline Overview 11.6.3 GlaxoSmithKline Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 GlaxoSmithKline Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 GlaxoSmithKline Recent Developments 11.7 Merck 11.7.1 Merck Corporation Information 11.7.2 Merck Overview 11.7.3 Merck Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Merck Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Merck Recent Developments 11.8 Novartis 11.8.1 Novartis Corporation Information 11.8.2 Novartis Overview 11.8.3 Novartis Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Novartis Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Novartis Recent Developments 11.9 Pfizer 11.9.1 Pfizer Corporation Information 11.9.2 Pfizer Overview 11.9.3 Pfizer Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Pfizer Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Pfizer Recent Developments 11.10 Roche 11.10.1 Roche Corporation Information 11.10.2 Roche Overview 11.10.3 Roche Anti-Infective Medications Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Roche Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Roche Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Anti-Infective Medications Industry Chain Analysis 12.2 Anti-Infective Medications Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Anti-Infective Medications Production Mode & Process 12.4 Anti-Infective Medications Sales and Marketing 12.4.1 Anti-Infective Medications Sales Channels 12.4.2 Anti-Infective Medications Distributors 12.5 Anti-Infective Medications Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Anti-Infective Medications Industry Trends 13.2 Anti-Infective Medications Market Drivers 13.3 Anti-Infective Medications Market Challenges 13.4 Anti-Infective Medications Market Restraints 14 Key Findings in The Global Anti-Infective Medications Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Anti-Infective Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Antivirals Table 3. Major Manufacturers of Antibacterials Table 4. Major Manufacturers of Antifungals Table 5. Global Anti-Infective Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Anti-Infective Medications Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Anti-Infective Medications Sales by Region (2017-2022) & (K Units) Table 8. Global Anti-Infective Medications Sales Market Share by Region (2017-2022) Table 9. Global Anti-Infective Medications Sales by Region (2023-2028) & (K Units) Table 10. Global Anti-Infective Medications Sales Market Share by Region (2023-2028) Table 11. Global Anti-Infective Medications Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Anti-Infective Medications Revenue Market Share by Region (2017-2022) Table 13. Global Anti-Infective Medications Revenue by Region (2023-2028) & (US$ Million) Table 14. Global Anti-Infective Medications Revenue Market Share by Region (2023-2028) Table 15. Global Anti-Infective Medications Sales by Manufacturers (2017-2022) & (K Units) Table 16. Global Anti-Infective Medications Sales Share by Manufacturers (2017-2022) Table 17. Global Anti-Infective Medications Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global Anti-Infective Medications Revenue Share by Manufacturers (2017-2022) Table 19. Anti-Infective Medications Price by Manufacturers (2017-2022) &(USD/Unit) Table 20. Global Anti-Infective Medications Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Anti-Infective Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Medications as of 2021) Table 22. Anti-Infective Medications Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Anti-Infective Medications Product Offered Table 24. Date of Manufacturers Enter into Anti-Infective Medications Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Anti-Infective Medications Sales by Type (2017-2022) & (K Units) Table 27. Global Anti-Infective Medications Sales by Type (2023-2028) & (K Units) Table 28. Global Anti-Infective Medications Sales Share by Type (2017-2022) Table 29. Global Anti-Infective Medications Sales Share by Type (2023-2028) Table 30. Global Anti-Infective Medications Revenue by Type (2017-2022) & (US$ Million) Table 31. Global Anti-Infective Medications Revenue by Type (2023-2028) & (US$ Million) Table 32. Global Anti-Infective Medications Revenue Share by Type (2017-2022) Table 33. Global Anti-Infective Medications Revenue Share by Type (2023-2028) Table 34. Anti-Infective Medications Price by Type (2017-2022) & (USD/Unit) Table 35. Global Anti-Infective Medications Price Forecast by Type (2023-2028) & (USD/Unit) Table 36. Global Anti-Infective Medications Sales by Application (2017-2022) & (K Units) Table 37. Global Anti-Infective Medications Sales by Application (2023-2028) & (K Units) Table 38. Global Anti-Infective Medications Sales Share by Application (2017-2022) Table 39. Global Anti-Infective Medications Sales Share by Application (2023-2028) Table 40. Global Anti-Infective Medications Revenue by Application (2017-2022) & (US$ Million) Table 41. Global Anti-Infective Medications Revenue by Application (2023-2028) & (US$ Million) Table 42. Global Anti-Infective Medications Revenue Share by Application (2017-2022) Table 43. Global Anti-Infective Medications Revenue Share by Application (2023-2028) Table 44. Anti-Infective Medications Price by Application (2017-2022) & (USD/Unit) Table 45. Global Anti-Infective Medications Price Forecast by Application (2023-2028) & (USD/Unit) Table 46. North America Anti-Infective Medications Sales by Type (2017-2022) & (K Units) Table 47. North America Anti-Infective Medications Sales by Type (2023-2028) & (K Units) Table 48. North America Anti-Infective Medications Revenue by Type (2017-2022) & (US$ Million) Table 49. North America Anti-Infective Medications Revenue by Type (2023-2028) & (US$ Million) Table 50. North America Anti-Infective Medications Sales by Application (2017-2022) & (K Units) Table 51. North America Anti-Infective Medications Sales by Application (2023-2028) & (K Units) Table 52. North America Anti-Infective Medications Revenue by Application (2017-2022) & (US$ Million) Table 53. North America Anti-Infective Medications Revenue by Application (2023-2028) & (US$ Million) Table 54. North America Anti-Infective Medications Sales by Country (2017-2022) & (K Units) Table 55. North America Anti-Infective Medications Sales by Country (2023-2028) & (K Units) Table 56. North America Anti-Infective Medications Revenue by Country (2017-2022) & (US$ Million) Table 57. North America Anti-Infective Medications Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe Anti-Infective Medications Sales by Type (2017-2022) & (K Units) Table 59. Europe Anti-Infective Medications Sales by Type (2023-2028) & (K Units) Table 60. Europe Anti-Infective Medications Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe Anti-Infective Medications Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe Anti-Infective Medications Sales by Application (2017-2022) & (K Units) Table 63. Europe Anti-Infective Medications Sales by Application (2023-2028) & (K Units) Table 64. Europe Anti-Infective Medications Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe Anti-Infective Medications Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe Anti-Infective Medications Sales by Country (2017-2022) & (K Units) Table 67. Europe Anti-Infective Medications Sales by Country (2023-2028) & (K Units) Table 68. Europe Anti-Infective Medications Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe Anti-Infective Medications Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific Anti-Infective Medications Sales by Type (2017-2022) & (K Units) Table 71. Asia Pacific Anti-Infective Medications Sales by Type (2023-2028) & (K Units) Table 72. Asia Pacific Anti-Infective Medications Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific Anti-Infective Medications Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific Anti-Infective Medications Sales by Application (2017-2022) & (K Units) Table 75. Asia Pacific Anti-Infective Medications Sales by Application (2023-2028) & (K Units) Table 76. Asia Pacific Anti-Infective Medications Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific Anti-Infective Medications Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific Anti-Infective Medications Sales by Region (2017-2022) & (K Units) Table 79. Asia Pacific Anti-Infective Medications Sales by Region (2023-2028) & (K Units) Table 80. Asia Pacific Anti-Infective Medications Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific Anti-Infective Medications Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America Anti-Infective Medications Sales by Type (2017-2022) & (K Units) Table 83. Latin America Anti-Infective Medications Sales by Type (2023-2028) & (K Units) Table 84. Latin America Anti-Infective Medications Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America Anti-Infective Medications Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America Anti-Infective Medications Sales by Application (2017-2022) & (K Units) Table 87. Latin America Anti-Infective Medications Sales by Application (2023-2028) & (K Units) Table 88. Latin America Anti-Infective Medications Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America Anti-Infective Medications Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America Anti-Infective Medications Sales by Country (2017-2022) & (K Units) Table 91. Latin America Anti-Infective Medications Sales by Country (2023-2028) & (K Units) Table 92. Latin America Anti-Infective Medications Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America Anti-Infective Medications Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa Anti-Infective Medications Sales by Type (2017-2022) & (K Units) Table 95. Middle East and Africa Anti-Infective Medications Sales by Type (2023-2028) & (K Units) Table 96. Middle East and Africa Anti-Infective Medications Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa Anti-Infective Medications Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa Anti-Infective Medications Sales by Application (2017-2022) & (K Units) Table 99. Middle East and Africa Anti-Infective Medications Sales by Application (2023-2028) & (K Units) Table 100. Middle East and Africa Anti-Infective Medications Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa Anti-Infective Medications Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa Anti-Infective Medications Sales by Country (2017-2022) & (K Units) Table 103. Middle East and Africa Anti-Infective Medications Sales by Country (2023-2028) & (K Units) Table 104. Middle East and Africa Anti-Infective Medications Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa Anti-Infective Medications Revenue by Country (2023-2028) & (US$ Million) Table 106. Abbott Corporation Information Table 107. Abbott Description and Major Businesses Table 108. Abbott Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 109. Abbott Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Abbott Recent Developments Table 111. Astellas Pharma Corporation Information Table 112. Astellas Pharma Description and Major Businesses Table 113. Astellas Pharma Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 114. Astellas Pharma Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 115. Astellas Pharma Recent Developments Table 116. Bayer Corporation Information Table 117. Bayer Description and Major Businesses Table 118. Bayer Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 119. Bayer Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Bayer Recent Developments Table 121. Bristol-Myers Squibb Corporation Information Table 122. Bristol-Myers Squibb Description and Major Businesses Table 123. Bristol-Myers Squibb Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 124. Bristol-Myers Squibb Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Bristol-Myers Squibb Recent Developments Table 126. Daiichi Sankyo Corporation Information Table 127. Daiichi Sankyo Description and Major Businesses Table 128. Daiichi Sankyo Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 129. Daiichi Sankyo Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Daiichi Sankyo Recent Developments Table 131. GlaxoSmithKline Corporation Information Table 132. GlaxoSmithKline Description and Major Businesses Table 133. GlaxoSmithKline Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 134. GlaxoSmithKline Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 135. GlaxoSmithKline Recent Developments Table 136. Merck Corporation Information Table 137. Merck Description and Major Businesses Table 138. Merck Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 139. Merck Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Merck Recent Developments Table 141. Novartis Corporation Information Table 142. Novartis Description and Major Businesses Table 143. Novartis Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 144. Novartis Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 145. Novartis Recent Developments Table 146. Pfizer Corporation Information Table 147. Pfizer Description and Major Businesses Table 148. Pfizer Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 149. Pfizer Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 150. Pfizer Recent Developments Table 151. Roche Corporation Information Table 152. Roche Description and Major Businesses Table 153. Roche Anti-Infective Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 154. Roche Anti-Infective Medications Product Model Numbers, Pictures, Descriptions and Specifications Table 155. Roche Recent Developments Table 156. Key Raw Materials Lists Table 157. Raw Materials Key Suppliers Lists Table 158. Anti-Infective Medications Distributors List Table 159. Anti-Infective Medications Customers List Table 160. Anti-Infective Medications Market Trends Table 161. Anti-Infective Medications Market Drivers Table 162. Anti-Infective Medications Market Challenges Table 163. Anti-Infective Medications Market Restraints Table 164. Research Programs/Design for This Report Table 165. Key Data Information from Secondary Sources Table 166. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Infective Medications Product Picture Figure 3. Global Anti-Infective Medications Market Share by Type in 2021 & 2028 Figure 3. Antivirals Product Picture Figure 4. Antibacterials Product Picture Figure 5. Antifungals Product Picture Figure 6. Global Anti-Infective Medications Market Share by Application in 2021 & 2028 Figure 7. Hospital Pharmacies Figure 8. Online Pharmacies Figure 9. Retail Pharmacies Figure 10. Anti-Infective Medications Report Years Considered Figure 11. Global Anti-Infective Medications Sales 2017-2028 (K Units) Figure 12. Global Anti-Infective Medications Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Anti-Infective Medications Revenue 2017-2028 (US$ Million) Figure 14. Global Anti-Infective Medications Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 15. Global Anti-Infective Medications Sales Market Share by Region (2017-2022) Figure 16. Global Anti-Infective Medications Sales Market Share by Region (2023-2028) Figure 17. North America Anti-Infective Medications Sales YoY (2017-2028) & (K Units) Figure 18. North America Anti-Infective Medications Revenue YoY (2017-2028) & (US$ Million) Figure 19. Europe Anti-Infective Medications Sales YoY (2017-2028) & (K Units) Figure 20. Europe Anti-Infective Medications Revenue YoY (2017-2028) & (US$ Million) Figure 21. Asia-Pacific Anti-Infective Medications Sales YoY (2017-2028) & (K Units) Figure 22. Asia-Pacific Anti-Infective Medications Revenue YoY (2017-2028) & (US$ Million) Figure 23. Latin America Anti-Infective Medications Sales YoY (2017-2028) & (K Units) Figure 24. Latin America Anti-Infective Medications Revenue YoY (2017-2028) & (US$ Million) Figure 25. Middle East & Africa Anti-Infective Medications Sales YoY (2017-2028) & (K Units) Figure 26. Middle East & Africa Anti-Infective Medications Revenue YoY (2017-2028) & (US$ Million) Figure 27. The Anti-Infective Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 28. The Top 5 and 10 Largest Manufacturers of Anti-Infective Medications in the World: Market Share by Anti-Infective Medications Revenue in 2021 Figure 29. Global Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 30. Global Anti-Infective Medications Sales Market Share by Type (2017-2028) Figure 31. Global Anti-Infective Medications Revenue Market Share by Type (2017-2028) Figure 32. Global Anti-Infective Medications Sales Market Share by Application (2017-2028) Figure 33. Global Anti-Infective Medications Revenue Market Share by Application (2017-2028) Figure 34. North America Anti-Infective Medications Sales Market Share by Type (2017-2028) Figure 35. North America Anti-Infective Medications Revenue Market Share by Type (2017-2028) Figure 36. North America Anti-Infective Medications Sales Market Share by Application (2017-2028) Figure 37. North America Anti-Infective Medications Revenue Market Share by Application (2017-2028) Figure 38. North America Anti-Infective Medications Sales Share by Country (2017-2028) Figure 39. North America Anti-Infective Medications Revenue Share by Country (2017-2028) Figure 40. U.S. Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 41. Canada Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 42. Europe Anti-Infective Medications Sales Market Share by Type (2017-2028) Figure 43. Europe Anti-Infective Medications Revenue Market Share by Type (2017-2028) Figure 44. Europe Anti-Infective Medications Sales Market Share by Application (2017-2028) Figure 45. Europe Anti-Infective Medications Revenue Market Share by Application (2017-2028) Figure 46. Europe Anti-Infective Medications Sales Share by Country (2017-2028) Figure 47. Europe Anti-Infective Medications Revenue Share by Country (2017-2028) Figure 48. Germany Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 49. France Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 50. U.K. Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 51. Italy Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 52. Russia Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 53. Asia Pacific Anti-Infective Medications Sales Market Share by Type (2017-2028) Figure 54. Asia Pacific Anti-Infective Medications Revenue Market Share by Type (2017-2028) Figure 55. Asia Pacific Anti-Infective Medications Sales Market Share by Application (2017-2028) Figure 56. Asia Pacific Anti-Infective Medications Revenue Market Share by Application (2017-2028) Figure 57. Asia Pacific Anti-Infective Medications Sales Share by Region (2017-2028) Figure 58. Asia Pacific Anti-Infective Medications Revenue Share by Region (2017-2028) Figure 59. China Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 60. Japan Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 61. South Korea Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 62. India Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 63. Australia Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 64. Taiwan Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 65. Indonesia Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 66. Thailand Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 67. Malaysia Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 68. Philippines Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 69. Latin America Anti-Infective Medications Sales Market Share by Type (2017-2028) Figure 70. Latin America Anti-Infective Medications Revenue Market Share by Type (2017-2028) Figure 71. Latin America Anti-Infective Medications Sales Market Share by Application (2017-2028) Figure 72. Latin America Anti-Infective Medications Revenue Market Share by Application (2017-2028) Figure 73. Latin America Anti-Infective Medications Sales Share by Country (2017-2028) Figure 74. Latin America Anti-Infective Medications Revenue Share by Country (2017-2028) Figure 75. Mexico Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 76. Brazil Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 77. Argentina Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 78. Middle East and Africa Anti-Infective Medications Sales Market Share by Type (2017-2028) Figure 79. Middle East and Africa Anti-Infective Medications Revenue Market Share by Type (2017-2028) Figure 80. Middle East and Africa Anti-Infective Medications Sales Market Share by Application (2017-2028) Figure 81. Middle East and Africa Anti-Infective Medications Revenue Market Share by Application (2017-2028) Figure 82. Middle East and Africa Anti-Infective Medications Sales Share by Country (2017-2028) Figure 83. Middle East and Africa Anti-Infective Medications Revenue Share by Country (2017-2028) Figure 84. Turkey Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 85. Saudi Arabia Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 86. U.A.E Anti-Infective Medications Revenue (2017-2028) & (US$ Million) Figure 87. Anti-Infective Medications Value Chain Figure 88. Anti-Infective Medications Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Abbott Astellas Pharma Bayer Bristol-Myers Squibb Daiichi Sankyo GlaxoSmithKline Merck Novartis Pfizer Roche